A
Akari Therapeutics plc
AKTX
3.77000
USD
-0.45
(-10.66%)
مغلق
حجم التداول
1
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
33,033,356
أصول ذات صلة
الأخبار
المقالات
العنوان: Akari Therapeutics plc
القطاع: Healthcare
الصناعة: Biotechnology
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).